Recoverability of renal functions after relief of partial ureteric obstruction of solitary kidney: Impact of ferulic acid

BJU International

Volumn 110, Issue 6, 2012, Pages 904-911

  Shokeir, Ahmed A ^a   Hussein, Abdel Aziz M ^b   Soliman, Shady A ^a   Kamal, Mohamed M ^a   Abdel Aziz, Azza ^c   Awadalla, Amira ^a   Rahim, Mona Abdel ^a   Barakat, Nashwa ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b Physiology Department   (Egypt)

^c MANSOURA UNIVERSITY   (Egypt)

Author keywords

ferulic acid; recoverability; solitary kidney; ureteric obstruction

Indexed keywords

CASPASE 3; CREATININE; FERULIC ACID; GLUTATHIONE; KI 67 ANTIGEN; MALONALDEHYDE; PROTEIN BCL 2; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFECT; FIBROSING ALVEOLITIS; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PARENCHYMA; LIPID PEROXIDATION; MALE; NEPHRECTOMY; NONHUMAN; OPERATION DURATION; PARTIAL URETERIC OBSTRUCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENOGRAPHY; SOLITARY KIDNEY; URETER OBSTRUCTION;

ANIMALS; COUMARIC ACIDS; DOGS; KIDNEY; KIDNEY DISEASES; MALE; RECOVERY OF FUNCTION; URETERAL OBSTRUCTION;

EID: 84865472793     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10848.x     Document Type: Article

References (38)

1. Cachat F, Lange-Sperandio B, Chang AY, et al,. Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. Kidney Int 2003; 63: 564-75
2. Schreiner GF, Harris KP, Purkerson ML, Klahr S,. Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int 1988; 34: 487-93
3. Sharma AK, Mauer SM, Kim Y, Michael AF,. Interstitial fibrosis in obstructive nephropathy. Kidney Int 1993; 44: 774-88
4. Vaughan ED Jr, Marion D, Poppas DP, Felsen D,. Pathophysiology of unilateral ureteral obstruction: studies from Charlottesville to New York. J Urol 2004; 172: 2563-9
5. Ito K, Chen J, Chaar M, et al,. Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats. Am J Physiol 2004; 287: F1283-93
6. Chevalier RL, Thornhill BA, Wolstenholme JT,. Renal cellular response to ureteral obstruction: role of maturation and angiotensin II. Am J Physiol 1999; 277: F41-7
7. Chevalier RL, Smith CD, Wolstenholme J, Krajewski S, Reed JC,. Chronic ureteral obstruction in the rat suppresses renal tubular Bcl-2 and stimulates apoptosis. Exp Nephrol 2000; 8: 115-22
8. Chan W, Krieg RJ Jr, Ward K, et al,. Progression after release of obstructive nephropathy. Ped Nephrol 2001; 16: 238-44
9. Ito K, Chen J, Seshan SV, et al,. Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats. Kidney Int 2005; 68: 515-28
10. Soliman SA, Shokeir AA, Mosbah A, et al,. Recoverability of renal function after relief of chronic partial unilateral ureteral obstruction: study of the effect of angiotensin receptor blocker (losartan). Urology 2010; 75: 848-52
11. Soliman SA, Shokeir AA, Mosbah A, et al,. Recoverability of renal function after relief of chronic partial unilateral ureteric obstruction: the effect of an angiotensin-converting enzyme inhibitor (enalapril). Arab J Urol 2011; 9: 67-71
12. Kawada N, Moriyama T, Ando A, et al,. Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int 1999; 56: 1004-13
13. Ricardo SD, Diamond JR,. The role of macrophages and reactive oxygen species in experimental hydronephrosis. Semin Nephrol 1998; 18: 612-21
14. Saborio P, Krieg RJ, Kuemmerle NB, Norkus EP, Schwartz CC, Chan JC,. Alpha-tocopherol modulates lipoprotein cytotoxicity in obstructive nephropathy. Pediatr Nephrol 2000; 14: 740-6
15. Pat B, Yang T, Kong C, et al,. Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int 2005; 67: 931-43
16. Akin M, Demirbilek S, Selma A, et al,. Attenuation of ureteral obstruction-induced renal injury by polyenylphosphatidylcholine. Int J Urol 2007; 14: 350-6
17. Srinivasan M, Sudheer AR, Menon VP,. Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr 2007; 40: 92-100
18. Khanduja KL, Avti PK, Kumar S, et al,. Anti-apopototic activity of caffeic acid, ellagic acid and ferulic acid in normal human peripheral blood mononuclear cells: a Bcl-2 independent mechanism. Biochim Biophys Acta 2006; 1760: 283-9
19. Guide for the care and use of Laboratory Animals. Laboratory Animal Research, National Research Council, Washington, DC, 1996. National Academy Press, no. 85-23, revised
20. Shokeir AA,. Partial ureteral obstruction: a new variable and reversible canine experimental model. Urology 1995; 45: 953-7
21. Edelstein CL, Cronin RE,. The patient with acute renal failure. In, Schrier RW, ed., Manual of Nephrology, London: Lippincott Williams &Wilkins, 2000; 132-5
22. Shokeir AA, Nljman RJM, El-Azab M, Provoost AP,. Partial ureteral obstruction: a study of Doppler ultrasonography and diuretic renography in different grades and duration of obstruction. Br J Urol 1996; 78: 829-35
23. Vielhauer V, Berning E, Eis V, et al,. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int 2004; 66: 2264-78
24. Duan WR, Garner DS, Williams SD, et al,. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol 2003; 199: 221-8
25. Lindboe CF, Torp SH,. Comparison of Ki-67 equivalent antibodies. J Clin Pathol 2002; 55: 467-71
26. Kerr WS Jr,. Effects of complete ureteral obstruction in dogs on kidney function. Am J Physio 1956; 184: 521-6
27. Vaughan ED Jr, Sorenson EJ, Gillenwater JY,. The renal hemodynamic response to chronic unilateral complete ureteral occlusion. Invest Urol 1970; 8: 78-90
28. Yagisawa M, Yuo A, Yonemaru M, et al,. Superoxide release and NADPH oxidase component in mature human phagocytes: correlation between functional capacity and amount of functional proteins. Biochem Biophys Res Commun 1996; 228: 510-6
29. Young M, Young I, Johnston S, Rowlands B,. Lipid peroxidation assessment of free radical production following release of obstructive uropathy. J Urol 1996; 156: 1828-32
30. Manucha W, Carrizo L, Ruete C, et al,. Angiotensin II type I antagonist on oxidative stress and heat shock protein 70 (HSP 70) expression in obstructive nephropathy. Cell Mol Biol (Noisy-le-grand) 2005; 51: 547-55
31. Sugiyama H, Kobayashi M, Wang DH, et al,. Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Nephrol Dial Transplant 2005; 20: 2670-80
32. Cvetkovic T, Vlahovic P, Pavlovic D, et al,. Low catalase activity in rats with ureteral ligation: relation to lipid peroxidation. Exp Nephrol 1998; 6: 74-7
33. Nowzari FB, Davidson SD, Eshghi M, et al,. Adverse effects of oxidative stress on renal cells and its prevention by antioxidants. Mol Urol 2000; 4: 15-9
34. Schaaf GJ, Nijmeijer SM, Maas RF, et al,. The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim Biophys Acta 2002; 1588: 149-58
35. Cuttle L, Zhang XJ, Endre ZH, et al,. Bcl-X(L) translocation in renal tubular epithelial cells in vitro protects distal cells from oxidative stress. Kidney Int 2001; 59: 1779-88
36. Yuan B, Liang M, Yang Z, et al,. Gene expression reveals vulnerability to oxidative stress and interstitial fibrosis of renal outer medulla to nonhypertensive elevations of ANG II. Am J Physio Regul Integr Comp Physiol 2003; 284: R1219-30
37. Zecher M, Guichard C, José Velásquez M, et al,. Implications of oxidative stress in the pathophysiology of obstructive uropathy. Urol Res 2009; 37: 19-26
38. Balasubashini MS, Rukkumani R, Menon VP,. Protective effects of ferulic acid on hyperlipidemic diabetic rats. Acta Diabetol 2003; 40: 118-22